Organisation
Nuclear Medicine
Current researchers
1 - 10 of 35 results
- Simon Arits (Member)
- Jesse Asiedu (Member)
- Kelly Boumon (Member)
- Sophie Bourgeois (Member)
- Amelientje Bracke (Member)
- Vicky Caveliers (Member)
- Veerle De Grove (Member)
- Lynn De Mey (Member)
- Steffi De Trif (Member)
- Jens Debacker (Member)
Projects
1 - 7 of 7
- Flanders BioImaging: Leading Imaging Application Integrated Service and Enablement (FBI-LIAISE).From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Development of a novel chemoenzymatic technology to generate radiofluorinated PET tracersFrom1 Nov 2021 → TodayFunding: FWO junior postdoctoral fellowship
- SBO project: Nanobody Life Time imaging to Enhance Surgery (NLITESurgery)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research (SBO)
- H2020: CSA: EURAMED rocc-n-roll: title EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspects (OZR EU BONUS)From1 Sep 2020 → 31 Aug 2023Funding: BOF - mobility
- H2020: CSA: EURAMED rocc-n-roll: title EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspectsFrom1 Sep 2020 → 31 Aug 2023Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)From1 Jan 2020 → TodayFunding: IOF - technology validation in real environment, IOF - mandates
- Connect 2018: IMMUNE-IMAGE: Specific Imaging of Immune Cell Dynamics Using Novel Tracer StrategiesFrom10 Oct 2018 → 11 Dec 2018Funding: Brussels Capital Region
Publications
11 - 20 of 105
- Pretreatment fluorodeoxyglucose positron emission tomography as predictive factor for the outcome of head and neck cancer patients.(2009)
Authors: Ashraf Farrag, Gaetane Ceulemans, Maria Voordeckers, Hendrik Everaert, Guy Storme
Pages: 477-477 - Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients(2021)
Authors: Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D Windhorst, Frank Van Der Aa, et al.
Pages: 1097-1105 - Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma(2016)
Authors: M Keyaerts, Catarina Xavier, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Chloé Ackaert, Marian Vanhoeij, Francois P Duhoux, Thierry Gevaert, Pascal Simon, et al.
Pages: 27-33 - 18F-FDG PET/CT in Waldenström associated amyloidosis(2023)
Authors: Lynn De Mey, Sim Vermeulen, Sophie Bourgeois, Lode Goethals, Frank De Geeter
Pages: 70-72 - Prediction of Response to Neoadjuvant Radiotherapy in Patients with Locally Advanced Rectal Cancer by Means of Sequential 18FDG-PET(2011)
Authors: Hendrik Everaert, A. Hoorens, C Vanhove, Alexandra Sermeus, G Ceulemans, Benedikt Engels, Marieke Vermeersch, Dirk Verellen, D. Urbain, Guy Storme, et al.
Pages: 91-96 - Oncologic outcomes after salvage laryngectomy for squamous cell carcinoma of the larynx and hypopharynx : a multicenter retrospective cohort study(2021)
Authors: Jeroen Meulemans, Jens Debacker, Hannelore Demarsin, Christophe Vanclooster, Peter Neyt, Tillo Mennes, Tom Vauterin, Wouter Huvenne, Annouschka Laenen, Pierre Delaere, et al.
Pages: 1751-1761 - Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy(2018)
Authors: Katrijn Broos, Q Lecocq, G Raes, Nick Devoogdt, M Keyaerts, K Breckpot
Pages: 3559-3570 - Development of potent and proteolytically stable human neuromedin U receptor agonists(2018)
Authors: An De Prins, Charlotte Martin, Yannick Van Wanseele, Louise Julie Skov, Csaba Tömböly, Dirk Tourwé, Vicky Caveliers, Ann Van Eeckhaut, Birgitte Holst, Mette Marie Rosenkilde, et al.
Pages: 887-897 - Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade(2021)
Authors: R M Awad, Q Lecocq, Katty Zeven, T Ertveldt, L De Beck, Hannelore Ceuppens, Katrijn Broos, Y De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.
Pages: 172-182 - Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer.(2020)
Authors: Yana Dekempeneer, Vicky Caveliers, Maarten Ooms, Dominic Maertens, Mireille Gysemans, Tony Lahoutte, Catarina Xavier, Q Lecocq, Ken Maes, Peter Covens, et al.
Pages: 3553-3566